8 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
23756063	25	The discovery of potent selective NPY Y(2) antagonists.	Janssen Research and Development
21684740	44	Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide.	Pfizer
19091559	59	Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.	Novartis Institutes For Biomedical Research
17276061	6	In vitro and in vivo profile of 5-[(4'-trifluoromethyl-biphenyl-2-carbonyl)-amino]-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide (dirlotapide), a novel potent MTP inhibitor for obesity.	Pfizer
16529928	72	Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents.	Pfizer
15380200	12	5-Carboxamido-1,3,2-dioxaphosphorinanes, potent inhibitors of MTP.	Bristol-Myers Squibb Pharmaceutical Research Institute
11741485	99	Diaminoindanes as microsomal triglyceride transfer protein inhibitors.	Novartis Institute For Biomedical Reasearch
11300866	14	A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors.	The Bristol-Myers Squibb Pharmaceutical Research Institute